These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26263120)

  • 1. Breakthrough pain in cancer patients: prevalence, mechanisms and treatment options.
    Mercadante S
    Curr Opin Anaesthesiol; 2015 Oct; 28(5):559-64. PubMed ID: 26263120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating breakthrough pain in oncology.
    Mercadante S
    Expert Rev Anticancer Ther; 2018 May; 18(5):445-449. PubMed ID: 29478355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled study of fentanyl buccal tablets for breakthrough pain: efficacy and safety in Japanese cancer patients.
    Kosugi T; Hamada S; Takigawa C; Shinozaki K; Kunikane H; Goto F; Tanda S; Shima Y; Yomiya K; Matoba M; Adachi I; Yoshimoto T; Eguchi K
    J Pain Symptom Manage; 2014 Jun; 47(6):990-1000. PubMed ID: 24099893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Italian Oncological Pain Survey (IOPS): a multicentre Italian study of breakthrough pain performed in different settings.
    Mercadante S; Lazzari M; Reale C; Cuomo A; Fusco F; Marchetti P; Mediati RD; Chiurazzi B; Ciuffedra L; Caraceni A; Iaffaioli V; Luzzani M; Micheletto G; Papa A; Raffaeli W; Valle A; Caruso M; Di Costanzo F; Pinato G; Nardi F; Barni S; Natoli S; Mammucari M; Sabato AF; Dauri M;
    Clin J Pain; 2015 Mar; 31(3):214-21. PubMed ID: 25654429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy for breakthrough cancer pain.
    Mercadante S
    Drugs; 2012 Jan; 72(2):181-90. PubMed ID: 22233484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacoeconomics of breakthrough cancer pain.
    Kuo KL; Saokaew S; Stenehjem DD
    J Pain Palliat Care Pharmacother; 2013 Jun; 27(2):167-75. PubMed ID: 23688496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acupuncture: a treatment for breakthrough pain in cancer?
    Paley CA; Johnson MI; Bennett MI
    BMJ Support Palliat Care; 2011 Dec; 1(3):335-8. PubMed ID: 24653480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study.
    Portenoy RK; Messina J; Xie F; Peppin J
    Curr Med Res Opin; 2007 Jan; 23(1):223-33. PubMed ID: 17207304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic cancer and noncancer pain: a randomized, double-blind, crossover study followed by a 12-week open-label phase to evaluate patient outcomes.
    Webster LR; Slevin KA; Narayana A; Earl CQ; Yang R
    Pain Med; 2013 Sep; 14(9):1332-45. PubMed ID: 23855816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of rapid onset opioids for breakthrough cancer pain: the challenge of its dosing.
    Mercadante S
    Crit Rev Oncol Hematol; 2011 Dec; 80(3):460-5. PubMed ID: 21215653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian variation of breakthrough pain in cancer patients.
    Saini A; Tucci M; Tampellini M; Maina D; Bouraouia K; Giuliano PL; Termine A; Castellano M; Campagna S; Laciura P; Berruti A
    Eur J Pain; 2013 Feb; 17(2):264-70. PubMed ID: 22715071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosing fentanyl buccal tablet for breakthrough cancer pain: dose titration versus proportional doses.
    Mercadante S; Gatti A; Porzio G; Lo Presti C; Aielli F; Adile C; Casuccio A
    Curr Med Res Opin; 2012 Jun; 28(6):963-8. PubMed ID: 22480130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of rapid-onset oral fentanyl formulations vs. oral morphine for cancer-related breakthrough pain: a meta-analysis of comparative trials.
    Jandhyala R; Fullarton JR; Bennett MI
    J Pain Symptom Manage; 2013 Oct; 46(4):573-80. PubMed ID: 23380337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Movement-evoked breakthrough cancer pain despite intrathecal analgesia: a prospective series.
    Bäckryd E; Larsson B
    Acta Anaesthesiol Scand; 2011 Oct; 55(9):1139-46. PubMed ID: 22092213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breakthrough pain in patients referred to pain clinics: the Italian pain network retrospective study.
    Gatti A; Mediati RD; Reale C; Cuomo A; Vellucci R; Russo G; Costantini A; Canneti A; Luzi M; Mammucari M; Sabato AF
    Adv Ther; 2012 May; 29(5):464-72. PubMed ID: 22622488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer.
    Portenoy RK; Taylor D; Messina J; Tremmel L
    Clin J Pain; 2006; 22(9):805-11. PubMed ID: 17057563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial.
    Mercadante S; Radbruch L; Davies A; Poulain P; Sitte T; Perkins P; Colberg T; Camba MA
    Curr Med Res Opin; 2009 Nov; 25(11):2805-15. PubMed ID: 19792837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of sublingual fentanyl for breakthrough pain by using doses proportional to opioid basal regimen.
    Mercadante S; Prestia G; Casuccio A
    Curr Med Res Opin; 2013 Nov; 29(11):1527-32. PubMed ID: 23869428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fentanyl buccal tablets for breakthrough pain in highly tolerant cancer patients: preliminary data on the proportionality between breakthrough pain dose and background dose.
    Mercadante S; Ferrera P; Adile C; Casuccio A
    J Pain Symptom Manage; 2011 Sep; 42(3):464-9. PubMed ID: 21477977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.